Gene: CYP2C9 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 Biomarker phenotype CTD_human Those who were carriers of CYP2C9 one-variant haplotypes (*1/*2 or *1/*3) were also found to be associated with the higher risk of bleeding events. 27581200 2016
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 Biomarker phenotype CTD_human The CYP2C9*3 allele may double the risk of major bleeding among patients taking warfarin for 30 or more days. 25521356 2014
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 Biomarker phenotype CTD_human The determination of CYP2C9 and VCORC1 genotypes in patients with APS before warfarin use allows excessive hypocoagulation and related hemorrhages to be avoided. 20597268 2010
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 Biomarker phenotype CTD_human [Cytochrome P4502C9(CYP2C9) gene polymorphism and safety of therapy with warfarin]. 18429757 2008
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 Biomarker phenotype CTD_human Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy. 18756910 2008
Entrez Id: 1559
Gene Symbol: CYP2C9
CYP2C9 		0.310 GeneticVariation phenotype LHGDN The variant CYP2C9 genotype is associated with an increased risk of major hemorrhage, which persists even after stabilization of therapy. 17653141 2008